Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million-March 2024-www.financetom.com

Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million

Aug 25, 2025 3:33 AM

Aug 25 (Reuters) - Royalty Pharma ( RPRX ) said on

Monday it has signed a deal with BeOne Medicines to acquire a

royalty interest in Amgen's ( AMGN ) drug for small cell lung

cancer for up to $950 million.

The deal gives Royalty Pharma ( RPRX ) access to roughly 7% of global

net sales of the therapy, which won U.S. approval last year for

patients with extensive-stage small cell lung cancer who have

failed chemotherapy.

Previous page： Home Depot Unusual Options Activity For June 12 Next page： --Urogen Pharma Shares Halted, Pending Material News Release

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Home Depot Unusual Options Activity For June 12

Jun 12, 2025

Whales with a lot of money to spend have taken a noticeably bullish stance on Home Depot ( HD ). Looking at options history for Home Depot ( HD ) we detected 12 trades. If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 41% with...

--Urogen Pharma Shares Halted, Pending Material News Release

Jun 12, 2025

12:01 PM EDT, 06/12/2025 (MT Newswires) -- Price: 7.17, Change: -0.13, Percent Change: -1.78 ...

Stock Yards Bancorp Insider Sold Shares Worth $312,000, According to a Recent SEC Filing

Jun 12, 2025

11:56 AM EDT, 06/12/2025 (MT Newswires) -- Laura L Wells, Director, on June 11, 2025, sold 4,000 shares in Stock Yards Bancorp ( SYBT ) for $312,000. Following the Form 4 filing with the SEC, Wells has control over a total of 14,954 common shares of the company, with 14,954 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/835324/000143774925020153/xslF345X05/rdgdoc.xml Price: 76.26, Change: +0.10,...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...